Importance Dexamethasone to prevent bronchopulmonary dysplasia in very preterm
neonates was associated with adverse neurodevelopmental events. Early low-dose …

Objective To determine whether early hydrocortisone treatment in extremely preterm infants
affects neurodevelopmental outcomes at 2 years of age according to gestational age at birth …

Importance Dexamethasone initiated after the first week of life reduces the rate of death or
bronchopulmonary dysplasia (BPD) but may cause long-term adverse effects in very preterm …

BACKGROUND. Low cortisol concentrations in premature infants have been correlated with
increased severity of illness, hypotension, mortality, and development of bronchopulmonary …

Background Bronchopulmonary dysplasia, a major complication of extreme prematurity, has
few treatment options. Postnatal steroid use is controversial, but low-dose hydrocortisone …

Early lung inflammation has been implicated in the pathogenesis of bronchopulmonary
dysplasia (BPD). We aimed to establish the efficacy and safety of systemic hydrocortisone …

Background: Corticosteroids have been used widely after birth in preterm infants with
respiratory failure; hydrocortisone may be preferable to other corticosteroids for this purpose …

Background Bronchopulmonary dysplasia is a prevalent complication after extremely
preterm birth. Inflammation with mechanical ventilation may contribute to its development …

Methods| The STOP-BPD study was performed in 16 neonatal intensive care units in the
Netherlands and Belgium (enrollment November 15, 2011, to December 23, 2016; final …

Background Randomized controlled trials have shown that treatment of chronically
ventilated preterm infants after the first week of life with dexamethasone reduces the …